Search

everythinglearnresearchcommunity

for

Search:↓

Women with moderate body hair have higher levels of certain hormones and may benefit from treatment that increases sex hormone-binding protein.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

Gene variant linked to prostate cancer, hormone levels, and hair loss.

The symptoms described align more with Haberland syndrome, not Delleman-Oorthuys syndrome.

Too much androgen can cause hair loss; finasteride may help.

Different STUB1 gene mutations cause varied symptoms in autosomal recessive ataxias.

Finasteride significantly reduces hair growth in women with idiopathic hirsutism.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

IPL can cause unexpected hair growth in nearby untreated areas.

Spironolactone can reduce hair growth and testosterone in hirsutism, but is less effective than combined treatments.

Certain ESR1 gene variations may affect hormone levels and fat distribution in women with high male hormone levels.

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

Women with Polycystic Ovary Syndrome (PCOS) have a higher risk of developing type 2 diabetes due to insulin resistance.

Higher DHT levels are linked to fewer hypogonadism symptoms in men with normal testosterone levels.

Using 17-hydroxyprogesterone levels to diagnose nonclassic congenital adrenal hyperplasia can result in many incorrect diagnoses.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Overweight women with PCOS are more likely to have excess male hormones.

Acanthosis nigricans in teenage girls with PCOS is a sign of obesity, not insulin resistance or glucose intolerance.

Balding and low testosterone increase risk of urinary stones.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Spinach-derived thylakoid supplements plus a low-calorie diet helped obese women with polycystic ovary syndrome lose weight and improve their metabolism.

Certain genetic variations in OCT1 may improve insulin sensitivity with metformin in women with PCOS.

African American women have a higher risk of preterm delivery than Caucasian women, and inflammatory stimuli affect gene expression in cells related to PCOS, showing a heightened inflammatory state in women with PCOS.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

The conclusion is that a thorough approach is needed to diagnose and manage hyperandrogenism in teenage girls, recognizing its major psychological and health effects.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.